The trial passed 2a and they are moving in to the next phase
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
AVR
anteris technologies global corp.
Add to My Watchlist
0.00%
!
$5.03

Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-4
-
- There are more pages in this discussion • 111 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.03 |
Change
0.000(0.00%) |
Mkt cap ! $77.98M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 374 | $5.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.75 | 2000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 374 | 5.050 |
3 | 870 | 5.030 |
2 | 500 | 5.020 |
3 | 1000 | 5.000 |
1 | 20000 | 4.920 |
Price($) | Vol. | No. |
---|---|---|
5.350 | 663 | 2 |
5.490 | 112 | 1 |
5.800 | 973 | 1 |
6.000 | 1900 | 2 |
6.400 | 450 | 2 |
Last trade - 09.51am 15/07/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable